KZR.D

Kezar Life Sciences, Inc.

Sector not classified

$199.39 sample

-0.35 (-0.18%) 1D

Market cap

$375.1B

Price as of

2026-10-24

Latest filing

8-K · 2026-10-02

Alerts

8

Price$199.39 +1.79% 3M daily closessample

208.72194.76

2026-07-282026-08-192026-09-102026-10-012026-10-23

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 21INSInsider sell: Chief Executive Officer
Oct 13INSInsider sell: 10% owner
Oct 07INSInsider buy: EVP, Operations
Oct 02SEC8-K filed: material event
Sep 25INSInsider sell: EVP, Operations
Sep 18INSInsider buy: EVP, Operations
Sep 14INSInsider sell: Chief Financial Officer
Sep 09INSInsider sell: Chief Financial Officer

Sign up to see the real KZR.D record →

Company facts

SEC EDGAR registration

Name: Kezar Life Sciences, Inc.
Sector: not classified
Industry: not classified
Smart-money score: +42sample, -100 to +100
Reporting currency: USD

Who is positioning in KZR.D

sample

Insiders: 30 insider transactions over 90 days, net selling, $748.0M
Congress: 1 members traded over 90 days
Institutions · 13F: 38 funds hold $4.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$22.4B +16.7% y/y

Q4 2024Q3 2026

Inventory$13.9B +15.8% y/y

Q4 2024Q3 2026

Accounts receivable$10.0B +12.7% y/y

Q4 2024Q3 2026

Total debt$26.6B +7.3% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $233.2B +1.4% 3M
Sample peer B: $72.8B +9.7% 3M
Sample peer C: $45.8B -11.2% 3M
Sample peer D: $205.6B +3.0% 3M
Sample peer E: $64.7B -4.1% 3M